Impact of interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphism on IgA nephropathy
- 1 August 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 58 (2) , 783-789
- https://doi.org/10.1046/j.1523-1755.2000.00227.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A promoter polymorphism of tumor necrosis factor α associated with systemic lupus erythematosus in African‐AmericansArthritis & Rheumatism, 1997
- Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in miceAmerican Journal of Kidney Diseases, 1997
- Interleukin-1 receptor antagonist allele: Is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy?Kidney International, 1997
- Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasisBritish Journal of Dermatology, 1997
- Serum Tumor Necrosis Factor in Mesangial IgA Glomerulonephntis with Macroscopic Hematuria in ChildrenNephron, 1996
- Extrarenal cytokines modulate the glomerular response to IgA immune complexesKidney International, 1992
- Single base polymorphism in the human Tumour Necrosis Factor alpha (TNFα) gene detectable by Ncol restriction of PCR productHuman Molecular Genetics, 1992
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- Macroscopic hematuria in mesangial IgA nephropathy: Correlation with glomerular crescents and renal dysfunctionKidney International, 1983
- IgA Nephropathy: Prognostic Significance of Proteinuria and Histological AlterationsNephron, 1983